Terlipressin Infusion During Whipple Procedure: Effect on Blood Loss and Transfusion Needs

PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

May 31, 2016

Primary Completion Date

July 31, 2017

Study Completion Date

July 31, 2017

Conditions
TerlipressinBlood Loss
Interventions
DRUG

Terlipressin

Terlipressin is a synthetic vasopressin analogue with relative specificity for the splanchnic circulation(Terlipressin was started at the beginning of surgery as an initial bolus dose of 1 mg over 30 mints(1 mg/50 ml normal saline at a rate of 100 ml/h) followed by a continuous infusion of 2 μg/kg/h(1 mg/50 ml at a rate equal to wt/10 ml per hour) and weaned in the postoperative period over 4 hours.)

DRUG

normal saline

Patients received 50 ml normal saline at a rate of 100 ml/h followed by a continuous infusion of 50 ml at a rate equal to wt/10 ml per hour and weaned in the postoperative period over 4 hours.

All Listed Sponsors
lead

Assiut University

OTHER

NCT03572088 - Terlipressin Infusion During Whipple Procedure: Effect on Blood Loss and Transfusion Needs | Biotech Hunter | Biotech Hunter